Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

A six gene expression signature defines aggressive subtypes and predicts outcome in childhood and adult acute lymphoblastic leukemia

Abstract : Abnormal gene expression in cancer represents an under-explored source of cancer markers and therapeutic targets. In order to identify gene expression signatures associated with survival in acute lymphoblastic leukemia (ALL), a strategy was designed to search for aberrant gene activity, which consists of applying several filters to transcriptomic datasets from two pediatric ALL studies. Six genes whose expression in leukemic blasts was associated with prognosis were identified:three genes predicting poor prognosis (AK022211, FASTKD1 and STARD4) and three genes associated with a favorable outcome (CAMSAP1, PCGF6 and SH3RF3). Combining the expression of these 6 genes could successfully predict prognosis not only in the two discovery pediatric ALL studies, but also in two independent validation cohorts of adult patients, one from a publicly available study and one consisting of 62 newly recruited Chinese patients. Moreover, our data demonstrate that our six gene based test is particularly efficient in stratifying MLL or BCR.ABL negative patients. Finally, common biological traits characterizing aggressive forms of ALL in both children and adults were found, including features of dormant hematopoietic stem cells, suggesting new therapeutic strategies.
Type de document :
Article dans une revue
Liste complète des métadonnées

https://hal.univ-grenoble-alpes.fr/hal-01879602
Contributeur : Brigitte Bidégaray-Fesquet <>
Soumis le : lundi 24 septembre 2018 - 10:25:20
Dernière modification le : vendredi 17 juillet 2020 - 11:39:01

Lien texte intégral

Identifiants

Collections

Citation

Jin Wang, Jian-Qing Mi, Alexandra Debernardi, Anne-Laure Vitte, Anouk Emadali, et al.. A six gene expression signature defines aggressive subtypes and predicts outcome in childhood and adult acute lymphoblastic leukemia. Oncotarget, Impact journals, 2015, 6 (18), pp.16527-16542. ⟨10.18632/oncotarget.4113⟩. ⟨hal-01879602⟩

Partager

Métriques

Consultations de la notice

238